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Abstract
Background: Staphylococcus aureus activates a protective cell wall stress stimulon (CWSS) in response to the
inhibition of cell wall synthesis or cell envelope damage caused by several structurally and functionally different
antibiotics. CWSS induction is coordinated by the VraSR two-component system, which senses an unknown signal
triggered by diverse cell wall active agents.
Results: We have constructed a highly sensitive luciferase reporter gene system, using the promoter of sas016 (S.
aureus N315), which detects very subtle differences in expression as well as measuring > 4 log-fold changes in
CWSS activity, to compare the concentration dependence of CWSS induction kinetics of antibiotics with different
cell envelope targets. We compared the effects of subinhibitory up to suprainhibitory concentrations of fosfomycin,
D-cycloserine, tunicamycin, bacitracin, flavomycin, vancomycin, teicoplanin, oxacillin, lysostaphin and daptomycin.
Induction kinetics were both strongly antibiotic- and concentration-dependent. Most antibiotics triggered an
immediate response with induction beginning within 10 min, except for tunicamycin, D-cycloserine and fosfomycin
which showed lags of up to one generation before induction commenced. Induction characteristics, such as the
rate of CWSS induction once initiated and maximal induction reached, were strongly antibiotic dependent. We
observed a clear correlation between the inhibitory effects of specific antibiotic concentrations on growth and
corresponding increases in CWSS induction kinetics. Inactivation of VraR increased susceptibility to the antibiotics
tested from 2- to 16-fold, with the exceptions of oxacillin and D-cycloserine, where no differences were detected
in the methicillin susceptible S. aureus strain background analysed. There was no apparent correlation between the
induction capacity of the various antibiotics and the relative importance of the CWSS for the corresponding
resistance phenotypes.
Conclusion: CWSS induction profiles were unique for each antibiotic. Differences observed in optimal induction
conditions for specific antibiotics should be determined and taken into account when designing and interpreting
CWSS induction studies.
Background
Staphylococcus aureus is a major cause of both nosoco-
mial and community-acquired infections worldwide.
Because staphylococci can adapt rapidly to varying
environmental conditions they are quick to develop
resistance to virtually all antibiotics and multiple-drug
resistance, especially in methicillin-resistant S. aureus
(MRSA), severely restricts antibiotic therapy options.
One of the major targets for antimicrobial agents is the
bacterial cell envelope, which is a complex, multi-
macromolecular structure that undergoes highly ordered
cycles of synthesis and hydrolysis, in order to facilitate
cell division while maintaining a protective barrier
against environmental stresses. There are several differ-
ent classes of antibiotics that target specific cell envel-
ope structures or enzymatic steps of cell wall synthesis
(Figure 1).
Many antibiotic resistance phenotypes in S. aureus are
influenced by global regulators that control virulence
factors, metabolism and/or stress responses [1]. One of
the latter is the VraSR system, which triggers the cell
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induced in S. aureus upon exposure to cell wall active
antibiotics, cell wall hydrolysis, or the inhibition of cell
wall synthesis, but not by other external stresses, such
as temperature, osmotic or pH extremes [1-3]. An
unknown signal, responding to cell wall stress, stimu-
lates the intramembrane sensor VraS to activate the
response regulator VraR by phosphorylation. When the
stress signal is relieved, VraR is subsequently deactivated
by VraS-specific dephosphorylation [4].
VraR, depending upon its phosphorylation state,
was shown to recognise VraR-responsive promoter
sequences and to control the expression of target genes
[5]. The phosphorylation kinetics suggested that VraSR
signal transduction was likely to respond very rapidly
in vivo [4]. A general stress signal, rather than the
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Figure 1 Schematic representation of the enzymatic steps involved in S. aureus cell wall synthesis and the targets of cell wall active
antibiotics. Fosfomycin inhibits the enzyme MurA (UDP-N-acetylglucosamine-3-enolpyruvyl transferase) that catalyses the addition of
phosphoenolpyruvate (PEP) to UDP-N-acetyl-glucosamine (GlcNAc) to form UDP-N-acetyl-muramic acid (UDP-MurNAc) [34]. D-cycloserine
prevents the addition of D-alanine to the peptidoglycan precursor by inhibiting D-alanine:D-alanine ligase A and alanine racemase [35].
Tunicamycin is a glycoprotein antibiotic that inhibits the transfer of peptidoglycan precursor (phospho-MurNAc-pentapeptide) to the lipid carrier
undecaprenyl pyrophosphate (or C55-isoprenyl pyrophosphate), catalysed by the translocase MraY [36,37]. Sub-lethal concentrations of
tunicamycin also inhibit TarO, the first enzyme in the wall teichoic acid pathway [38,39]. Bacitracin forms a metal-dependent complex with the
lipid carrier undecaprenyl pyrophosphate, thereby preventing dephosphorylation and the recycling of the lipid carrier required for cell wall
synthesis [40,41]. Flavomycin (a moenomycin complex) is a phosphoglycolipid antibiotic that inhibits transglycosylation through binding of the
transglycosylase domain of penicillin-binding protein 2 (PBP2) [42]. Glycopeptide antibiotics, such as vancomycin and teicoplanin, inhibit cell wall
synthesis by binding the D-ala-D-ala of the lipid II and sterically hindering transglycosylation and transpeptidation. Teicoplanin activity is
enhanced through its interaction with the cytoplasmic membrane [43]. ß-lactam antibiotics, such as oxacillin, bind the transpeptidase active
domain of penicillin-binding proteins (PBPs) by mimicking the D-ala-D-ala end of the pentapeptide [44]. The mode of action of daptomycin is
not fully known, it causes calcium-dependent disruption of membrane function and potassium efflux [45], but was also predicted to directly or
indirectly inhibit peptidoglycan systhesis [9]. Lysostaphin is a zinc metalloenzyme that cleaves the pentaglycine crosslinking bridge specific for
the cell wall of S. aureus [46]. (Adapted from [47]).
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Page 2 of 11antibiotics themselves, was proposed to initiate CWSS
induction [6-8]. This hypothesis is supported by the fact
that the CWSS is induced by several different cell wall
antibiotics with different targets and/or modes of action
as well as by the inhibition of cell wall synthesis result-
ing from reduction of PBP2 and MurF expression
[6,7,9].
Upregulation of the CWSS provides a certain level of
resistance/tolerance to most VraSR-inducing agents,
although the exact stress response coordinated has not
been fully characterised. Core CWSS genes include:
murZ (MurA isozyme), involved in the early steps of cell
wall biosynthesis [10]; pbp2 and sgtB,i n v o l v e di nt r a n s -
glycosylation; and fmtA, a penicillin binding protein with
low affinity to b-lactams [3,11,12]. Therefore activation
of the CWSS is predicted to enhance cell wall synthesis
[2]. This is substantiated by the identification of clinical
isolates with point mutations in the vraSR operon that
lead to increased basal expression of the CWSS in the
absence of inducing agents, with the resulting phenotypes
including thickened cell walls and increased levels of gly-
copeptide and ß-lactam resistance [13,14].
The VraSR system of S. aureus has been found to be
induced by a much wider range of cell wall active anti-
biotics than the homologous LiaRS systems of Bacillus
subtilis and Streptococcus mutans,w h i c ha r eo n l y
induced by lipid II-interacting antibiotics and not by
those that inhibit the earlier or later stages of cell wall
synthesis [15-18]. However, the sizes and compositions
of VraSR regulons reported so far vary quite extensively
and appear to be heavily dependent upon the strains
and experimental procedures used. Huge variations in
levels of CWSS gene induction were found not only to
be dependent upon the types of antibiotic used but also
on the antibiotic concentrations [2,19,20].
In this study we created a highly sensitive reporter
gene construct to indirectly measure the kinetics of
VraSR-dependent signal transduction in the presence of
antibiotic concentrations ranging from sub- to supra-
minimum inhibitory concentrations (MIC), for a selec-
tion of antibiotics with different cell envelope targets
(Figure 1). This allowed us to compare maximal induc-
tion capacities and determine optimal conditions,
including concentrations and exposure times, for mea-
suring CWSS induction by different antibiotics.
Methods
Bacterial strains and growth conditions
The strains and plasmids used in this study are listed in
Table 1. Bacteria were grown at 37°C in Luria Bertani
(LB) broth (Difco Laboratories), shaking at 180 rpm
with a 1:5 culture to air ratio, or on LB agar plates. All
optical density (OD) measurements given were taken at
OD 600 nm. Media were supplemented with the following
antibiotics when appropriate: 10 μg/ml tetracycline
(Sigma), 10 μg/ml chloramphenicol (Sigma), 100 μg/ml
ampicillin (Sigma) or 200 ng/ml anhydrotetracycline
(Vetranal). Strains were stored at -80°C in skim milk.
Susceptibility tests
The MICs of antibiotics were determined by Etest (Bio-
Mérieux) on LB plates swabbed with an inoculum of 0.5
McFarland and incubated at 37°C for 24 h. The MICs of
flavomycin, D-cycloserine, tunicamycin and lysostaphin
Table 1 Strains and plasmids
Strain/
plasmid
Relevant genotype
a Reference/
source
S. aureus
RN4220 Restriction-negative derivative of NCTC8325-4 [48]
BB255 NCTC8325 derivative, cured of plasmid pI524 [49]
BB255ΔVraR BB255 containing vraR mutation, truncating VraR after the 2
nd amino acid This study
E. coli
DH5a F
- 80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rk
-,m k
+) phoA supE44 thi-1 gyrA96 relA1l
- Invitrogen
Plasmids
pSP-luc+ Luciferase fusion plasmid, ori ColE1, bla, luc+; Ap
r Promega
pBUS1 E. coli - S. aureus shuttle vector, tetL ;T c
r [31]
pKOR1 E. coli - S. aureus shuttle plasmid, for creating markerless deletions; repF (ts), cat, attP, ccdB, ori ColE1, bla,P xyl/tetO,
secY570;A p
r,C m
r
[25]
pKOR1-VraR::
stop
pKOR1 construct containing mutant vraR insert with XhoI site and two inframe stop codons inserted between the
2
nd and 3
rd vraR codons.
[26]
psas016p-luc+ pBUS1 containing the sas016 promoter-luciferase reporter gene fusion [26]
ptcaAp-luc+ pBUS1 containing the tcaA promoter-luciferase reporter gene fusion This study
psa0908p-luc+ pBUS1 containing the sa0908 promoter-luciferase reporter gene fusion This study
aAbbreviations: Tc
r, tetracycline resistance; Ap
r, ampicillin resistance; Cm
r, chloramphenicol resistance.
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tially as recommended by the Clinical and Laboratory
Standards Institute [21].
Northern Blots
Northern blots were performed as previously described
[22]. Overnight cultures were diluted to OD 0.05 in pre-
warmed LB containing tetracycline and grown to
approximately OD 0.5. Cultures were induced with
increasing concentrations of oxacillin and a control cul-
ture was grown without antibiotic treatment. Samples
were taken after 20 min and 60 min of induction and
total RNA was extracted as described by Cheung et al.
[23]. RNA samples (7 μg) were separated in a 1.5% agar-
ose-20 mM guanidine thiocyanate gel in 1 × TBE buffer
[24]. Digoxigenin (DIG)-labelled probes were amplified
using the PCR DIG Probe synthesis kit (Roche) and pri-
mer pairs SAS016.for (TCATACGTTCTATGTCTGAT)
and SAS016.rev (GATCTATATCGTCTTGTAAT); and
luc+ (GGCAATCAAATCATTCCGGATACTG) and
luc- (ATCCAGATCCACAACCTTCGCTTC).
Construction of vraR mutant
The pKOR1 system developed by Bae et al. [25] was
used to inactivate VraR in BB255, by inserting an XhoI
site and two stop codons in-frame into the beginning of
the vraR coding sequence, truncating VraR after the 2
nd
amino acid, as previously described [26].
Luciferase reporter gene fusions
Promoter regions of sas016 (SACOL0625),t c a Aand
sa0908 (SACOL1065) were PCR amplified from S. aureus
strain COL using primer pairs: sas016.lucF (AATTAGG-
TACCTGGATCACGGTGCATACAAC) and sas016.lucR
(AATTACCATGGCCTATATTACCTCCTTTGC); tcaA.
lucF (TAATGGTACCAGTATTAGAAGTCATCAATCA)
and tcaA.lucR (TAAT CCATGGTTTCACCTCAAT
TCTGTTCCT), and sa0908.lucF (AATTAGGTACCA
TAA TAGTACACACGCATGT) and sa0908.lucR
(TTAATCCATGGTTGATGCTCCTA TATTAAATT),
respectively. PCR products were digested with Asp718 and
NcoI and ligated directly upstream of the promoterless
luciferase (luc+) gene in vector pSP-luc+ (Promega). Frag-
ments containing the resulting promoter-luc+ transla-
tional fusions were then excised with Asp718 and EcoR1
a n dc l o n e di n t ot h eE. coli - S. aureus shuttle vector
pBUS1 (Table 1). The fusion plasmids ptcaAp-luc+,
psa0908p-luc+a n dp sas016p-luc+ (Table 1) were then
electroporated into S. aureus RN4220 before being trans-
duced, by phage 80a,i n t oS. aureus BB255.
Luciferase assays for quantification of promoter induction
For induction assays, pre-warmed LB broth was inocu-
lated with an overnight culture to an OD of 0.05.
Cultures were grown to OD 0.3 - 0.5 and pre-induction
samples were collected before the cultures were induced
with increasing concentrations of the antibiotics: fosfo-
mycin (disodium salt, Sigma), D-cycloserine (Sigma),
bacitracin (from Bacillus lincheniformis, Sigma), vanco-
mycin (Vancocin, Eli Lilly), teicoplanin (Hoechst Marion
Roussel), oxacillin (InfectoPharm), flavomycin (BC Bio-
chemie GmbH), daptomycin (Cubist Pharmaceuticals),
tunicamycin (AG Scientifics) and lysostaphin (ambicin,
AMBI). Medium was supplemented with 25 μg/ml ZnCl
for bacitracin, 50 μg/ml CaCl2 for daptomycin and
25 μg/ml glucose-6-phosphate for fosfomycin experiments.
Samples were then collected and the OD measured after
10, 20, 30, 45, 60 and 120 min. For each sample, 1 ml of
culture was harvested by centrifugation and the pellets
frozen at -20°C. To measure the luciferase activity, pellets
were thawed briefly and resuspended in PBS (pH 7.4) to
an OD of either 10 or 1, depending on induction levels.
Aliquots of the cell suspensions were then mixed with
equal aliquots of Luciferase Assay System substrate (Pro-
mega) and luminescence was measured for 15 s after a
delay of 3 s on a Turner Designs TD-20/20 luminometer
(Promega) in relative light units (RLU).
For the determination of colony forming units per
millilitre (CFU/ml), 1 ml samples of cultures that had
been induced for 120 min with 1xMIC of each antibiotic
were harvested by centrifugation. Cell pellets were
resuspended in 0.85% NaCl and immediately diluted and
plated on sheep-blood agar plates.
Results and Discussion
Comparison of CWSS reporter constructs
To quantify CWSS induction and follow its time course
upon antibiotic exposure, the promoters of the three
representative CWSS genes sas016, sa0908 and tcaA,
were fused to the luciferase reporter gene and the
resulting plasmids were introduced into antibiotic sus-
ceptible strain BB255. sas016 encodes a hypothetical
protein of unknown function and was the open reading
frame (ORF) found to be most strongly up-regulated by
cell wall antibiotics in several studies [3,11,20]; tcaA
encodes a predicted membrane protein that influences
glycopeptide resistance and virulence in a nematode
model and belongs to the core S. aureus CWSS
[11,22,27]; and sa0908 encodes an envelope protein that
influences lytic behaviour in S. aureus and is one of a
family of three LytR-CpsA-Psr proteins that are all
induced by cell wall stress (unpublished results).
Increasing concentrations of oxacillin were added to
exponentially growing cultures containing reporter plas-
mids, and the OD and luciferase activities were mea-
sured over a two hour period (Figure 2). The three
promoters were all induced in a concentration depen-
dent manner, with induction lag times becoming shorter
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increased. This was mirrored by a corresponding step-
wise decrease in growth rates. Induction rates generally
began to slow after 60 min, upon the onset of oxacillin
induced lysis [28], but again this was concentration
dependent with induction rates beginning to decrease
earlier in cultures with higher oxacillin concentrations.
Previous findings, using Northern blots to measure
oxacillin induction levels of sas016 after 30 min, indi-
cated that inhibitory concentrations of oxacillin were
required for induction [20]. Figure 2 confirmed that the
sub-inhibitory concentration of 0.5x MIC did not
noticeably induce promoter activity after 30 min, how-
ever, luciferase activity from all three promoters began
to increase sharply after 60 min and continued to rise
up to the final sampling point of 120 min.
Although all three promoters displayed similar relative
concentration- and time-dependent induction kinetics, the
sas016 promoter produced the highest levels of luciferase
activity, resulting in greater fold-changes between samples
and making it the most sensitive of the three reporters.
Therefore we chose the sas016 promoter-luciferase fusion
construct as the best indicator to compare induction char-
acteristics of different cell wall active antibiotics.
Correlation between sas016 transcript induction and
luciferase activity from psas016p-luc+
To confirm that levels of luciferase activity from
psas016p-luc+ accurately represented levels of sas016
gene expression, Northern blots were performed on
BB255 psas016p-luc+ RNA samples extracted from
cultures grown using the same conditions and oxacillin
concentrations used for luciferase assays. Samples were
harvested 20 min and 60 min after antibiotic induction
and hybridized with sas016 and luc+s p e c i f i cD I G
probes (Figure 3). Northern blots showed identical pat-
terns of transcriptional induction for both the chromo-
somal sas016 gene and the luciferase gene under the
control of the sas016 promoter in psas016p-luc+. Induc-
tion of both transcripts was highly oxacillin-concentra-
tion dependent and transcript intensities increased over
time becoming stronger after 60 min than after 20 min,
correlating very well with concentration-specific induc-
tion curves from luciferase assays (Figure 2).
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Figure 2 Induction kinetics of three CWSS promoters in response to varying concentrations of oxacillin. Luciferase activities and growth
curves of strain BB255 containing: A, psas016-luc+; B, psa0908-luc+; and C, ptcaA-luc+; after addition of 0, 0.5, 1, 2 or 5-fold the MIC of oxacillin
at time point zero.
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Figure 3 Northern blot analysis of sas016 and sas016p-luc+
transcript induction BB255 psas016p-luc+. RNA was harvested
from cultures after 20 and 60 min of induction with 0, 0.2, 0.5, 1, 2
or 5-fold MIC concentrations of oxacillin. Transcripts hybridising to
sas016 and luc+-specific DIG and their approximate sizes are
indicated. Approximate transcript sizes are indicated on the left side
of the blots. Ethidium bromide stained 16S rRNA bands are shown
below Northern blots as an indication of RNA loading.
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The MIC values of diverse antibiotics chosen for induc-
tion experiments were determined for strain BB255
psas016p-luc+ (Table 2). MIC concentrations were then
used in induction experiments to compare the relative
inducing capacities of the antibiotics (Figure 4). When
adding MIC concentrations of antibiotics to exponen-
tially growing cultures, salient differences in induction
kinetics were apparent throughout the two hour sam-
pling period, including the slopes of induction curves
and the maximal luciferase activities reached. Large dif-
ferences were also seen in the response of the culture’s
ODs over the induction period, which ranged from
slight growth retardation, through to halting of growth
and decreasing OD readings; reflecting differences in the
effectiveness of the antibiotics and the concentrations
used, which are likely to impact CWSS induction
kinetics. There were no apparent connections between
the stages of cell wall synthesis targeted by antibiotics
and CWSS induction potential. Oxacillin and fosfomy-
cin, which target completely different enzymatic stages
of peptidoglycan synthesis, showed the highest maximal
induction levels, with luciferase activity becoming
induced relatively late, but then continually increasing
over the two hour period. Bacitracin, tunicamycin, D-
cycloserine, flavomycin and teicoplanin showed medium
levels of induction, although there were large differences
in the shapes of their induction curves. Bacitracin and
flavomycin initiated induction very rapidly and maximal
expression peaked after 60 min. The teicoplanin induc-
tion curve was shallower but maximal induction was
again reached at 60 min. Vancomycin was a comparably
weak inducer at the MIC concentration. Induction by
lysostaphin appeared immediately, within the first
10 min, but remained very low. The OD curve for
lysostaphin showed significant lysis of the culture, which
would account for the overall low levels of luciferase
measured. Induction therefore seems to be more
strongly influenced by the specific activities of the differ-
ent antibiotics used, rather than their targets.
Concentration-dependent CWSS induction kinetics
Large differences were observed in the CWSS induction
kinetics of antibiotics when used at MIC levels, however,
these concentrations may not have represented the
Table 2 MIC values and summary of induction kinetics characteristics of different antibiotics
Antibiotic MIC
a Fold MIC decrease in
BB255ΔVraR
b
Lag before
induction
c
Maximum
induction
d
Time point of
maximum induction
e
Concentration
dependence
f
OD/CFU/ml as %
of control
g
Fosfomycin 0.5 2x 30 high 120 high (29.5) 47/10
D-
Cycloserine
12 none 10 medium 60 high (25.5) 56/36
Bacitracin 32 10x none medium 60 low (1.5) 26/9
Tunicamycin 8 4x 10 high 120 medium (3.0) 38/9
Flavomycin 4 16x none high 60 low (1.6) 41/25
Vancomycin 1.3 2x none low 120 medium (12.6) 100/100
Oxacillin 0.2 none none high 120 high (19.1) 74/20
Daptomycin 0.25 2x none low 120 medium (14.1) 85/75
Lysostaphin 0.065 2x none low 10 medium (11.3) 11/6
Teicoplanin 0.5 10x none medium 60 medium (7.5) 91/83
aDetermined in μg/ml for BB255 psas016-luc+.
bDifference in MIC values of BB255/BB255ΔVraR.
cEarliest time point at which induction was detected (min).
dInduction levels were scored as: high (> 40’000 RLU); medium (>10’000 - < 40’000); low (< 10’000).
eTime taken for maximum induction to be reached after
antibiotic addition (min).
fThe ratio of maximal induction levels measured at 5x MIC/0.2x MIC, scored as: high (> 15); medium (>2 - < 15); low (< 2).
g OD and
CFU/ml values after treatment with antibiotics (1x MIC) for 120 min, expressed as a percentage of the values from untreated cell.
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Figure 4 Antibiotic dependent induction of the cell wall stress
stimulon. The upper graph shows relative light units (RLU)
measured upon induction of BB255 psas016p-luc+ of cultures
stressed with 1x MIC of different antibiotics. The corresponding OD
values at each sampling point are presented below. The graphs
shown are representative results of between two and four induction
experiments performed for each antibiotic.
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Page 6 of 11optimal induction conditions for all of the antibiotics.
Therefore, induction assays were performed as above, but
using five different antibiotic concentrations ranging from
sub- up to supra-inhibitory (Figure 5). Additionally, cipro-
floxacin, a flouroquinolone antibiotic that does not target
the cell envelope was included as a control at concentra-
tions of 2x and 5x the MIC (MIC = 0.2 μg/ml).
Tunicamycin, flavomycin, oxacillin and fosfomycin
triggered the highest maximal induction levels (RLU >
40’000) (Figure 5A, Table 2). Bacitracin, D-cycloserine,
teicoplanin, and vancomycin showed medium levels of
induction (RLU > 10’000 - < 40’000), while daptomycin
and lysostaphin were the weakest inducers (RLU <
10’000) (Figure 5, Table 2). Daptomycin is known to
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Figure 5 Concentration-dependent cell wall stress stimulon induction kinetics of different cell wall active antibiotics. Graphs show
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Page 7 of 11target the bacterial cell membrane, causing membrane
depolarization and potassium efflux (Figure 1), however
because of its ability to trigger the CWSS it is also
thought to directly or indirectly interfere with peptido-
glycan synthesis [9], although the mechanism by which
this occurs is unknown.
Ciprofloxacin treated cells showed no luciferase induc-
tion after 60 min and although levels were up to 2-fold
higher than in untreated cells after two hours, no
further increases in expression were detected, even after
four hours when the OD started to decrease in response
to the ciprofloxacin treatment. Therefore marginal
increases were unlikely to be caused by ciprofloxacin-
specific induction of the CWSS as even the lowest indu-
cers, lysostaphin and daptomycin, stimulated 18-fold
and 14-fold induction, respectively.
Shapes of the induction curves were different for all of
the antibiotics tested. Most of the antibiotics triggered
immediate induction of the CWSS, with lysostaphin
producing the strongest and most rapid response within
the first 10 min, followed by flavomycin, bacitracin, dap-
tomycin, vancomycin, teicoplanin and oxacillin. Contra-
rily, fosfomycin and D-cycloserine showed a lag phase of
induction for all concentrations of approximately
30 min and 10 min, respectively, before any induction
could be detected. Tunicamycin also showed a 10 min
lag phase for all concentrations except 5x MIC, for
which a slight 3-fold induction could be measured at
the 10 min sampling point. Fosfomycin, D-cycloserine
and tunicamycin act on early steps of peptidoglycan
synthesis (Figure 1), which could be linked to the lags in
CWSS induction. Balibar et al. also detected a lag phase
of CWSS induction when S. aureus was treated with the
UPP synthesis inhibitor hymeglusin [29].
Concentration-dependence was categorized based on
the spread of the induction curves, so that antibiotics
with large distances between the curves for different
concentrations were scored as being highly concentra-
tion-dependent; while those in which the majority of
curves clustered closely together were scored as having
low dependence. The concentration-dependency of
induction was also evaluated by determining the ratio of
the induction measured at 5x MIC over that at 0.2x
MIC (Table 2). Accordingly, fosfomycin, D-cycloserine,
oxacillin, tunicamycin, vancomycin, daptomycin and
lysostaphin showed relatively high concentration-depen-
dency (ratio >2). Some of these antibiotics such as fosfo-
mycin, oxacillin and daptomycin had quite evenly spread
curves that generally increased incrementally as concen-
trations became higher. Whereas for vancomycin, there
was a gap between the supra-MIC curves which both
showed relatively high induction, and all of the sub-MIC
curves that exhibited very little induction. In different
experiments curves corresponding to the vancomycin
MIC vacillated between showing either mid-level induc-
tion or clustering with the sub-MIC curves, indicating
that the MIC of vancomycin was very close to the
threshold concentration required for CWSS induction.
Flavomycin and bacitracin induction curves also
increased incrementally as concentrations increased, but
the gaps between the curves were much smaller than
for most of the other antibiotics (ratio < 2).
Previous studies have reported contradictory results
regarding the induction of the CWSS by lysostaphin.
Some studies detected no induction of the CWSS by lysos-
taphin [19,30], while Rossi et al. detected a slight induction
of the CWSS gene mrsR upon lysostaphin treatment [31].
Possible reasons for these discrepancies are likely to be
linked to experimental variations in the strains, lysostaphin
concentrations and induction times used, or the sensitivity
of induction detection methods. In this study, lysostaphin
induction could only be detected under very specific
experimental conditions (Figure 5B).
The influences of antibiotic concentrations on CWSS
induction kinetics generally correlated closely with the
impacts of the corresponding concentrations on the OD
of the cultures (Figure 5). For example, the incremental
increases in oxacillin induction curves closely mirrored
corresponding decreases in culture OD curves. For fla-
vomycin, all of the concentrations used induced lucifer-
ase activity to similar levels and all growth curves were
correspondingly inhibited to similar extents. All experi-
ments showed a definite correlation, albeit to different
extents, between levels of growth arrest in the cultures
and corresponding levels of CWSS induction. This trend
is not always proportional, however, as bacitracin and
tunicamycin OD curves showed a large degree of spread
whereas induction curves were more closely clustered.
To compare how decreases in OD correlated with cell
viability, CFU/ml were measured after treatment with 1x
MIC of each antibiotic for two hours. The percentage
decrease in CFU/ml generally corresponded well with
the percentage decrease in OD (Table 2).
Impact of VraR inactivation on resistance to the cell wall
antibiotics tested
Deletion of the vraSR operon is known to decrease resis-
tance levels to most of its inducing antibiotics [2,6,9,32].
However, the reported effects on different resistance phe-
notypes varied greatly, with some MICs unaffected while
others were decreased up to 40-fold; indicating that
induction of the CWSS is more essential for protecting S.
aureus against some antibiotics than others [2,6,32].
To determine if there was a link between levels or
kinetics of CWSS induction and the importance of the
CWSS for corresponding resistance phenotypes, we
determined the MICs of BB255 compared to
BB255ΔVraR for all of the antibiotics tested above and
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BB255ΔVraR contains a non-polar deletion truncating
VraR after the 2
nd amino acid, while leaving the autore-
gulatory operon intact. The impact of VraR inactivation
on resistance phenotypes was very similar to those pre-
viously published for deletion of vraSR in S. aureus
N 3 1 5[ 2 ] .T h em a j o r i t yo fM I C sd e c r e a s e di nt h eV r a R
mutant compared to the parent strain BB255 (Table 2).
The largest impact seen was on the flavomycin MIC,
which decreased 16-fold. Bacitracin and teicoplanin
MICs were also much lower, with both reduced by
10-fold, and were similar to values previously published
for vraSR null-mutants [2]. In contrast to Pietiänen et
al. [32], who saw no effects on the vancomycin MIC in
a vraSR deletion mutant of strain Newman, we observed
a 2-fold decrease in vancomycin MIC, similar to that
observed by Kuroda et al. in strain N315 [2]. Our
results, which showed a weak 2-fold reduction in fosfo-
mycin MIC and no impact on D-cycloserine resistance,
also agreed with those obtained for the N315 vraSR
deletion mutant. While previous reports gave conflicting
results concerning the effect of VraSR inactivation on
daptomycin resistance [9,32], we observed a reproduci-
ble 2-fold reduction in MIC upon VraR inactivation,
supporting results from Muthaiyan et al. [9].
Inactivation of VraR had no effect on oxacillin resis-
tance in the methicillin susceptible S. aureus (MSSA)
strain BB255. However, inactivation of vraR in BB270,
an MRSA isogenic to BB255 that contains a type I
SCCmec, reduced the oxacillin MIC from >256 to 64
μg/ml [26], to similar levels as those reported for other
vraSR mutants in MRSA strains [2,6,33]. Loss of VraR
also rendered the mutant 2-fold more susceptible to the
action of lysostaphin and 4-fold more susceptible to
tunicamycin; phenotypes which have not been pre-
viously published for VraSR mutants.
These results confirmed that the ability to induce the
cell wall stress stimulon confers varying levels of protec-
tion against the effects of cell wall active agents. However,
comparison of our MIC results with our induction data
revealed no clear links between how quickly, or to which
maximal level, the antibiotics are able to induce the CWSS
and the impact of a functional VraSR signal transduction
response on resistance levels to those antibiotics.
The sas016 promoter-luciferase fusion construct was
also analysed in BB255ΔVraR. Expression levels of
psas016p-luc+ in BB255ΔVraR in uninduced samples
were ~10-fold lower than in the wild type BB255.
BB255ΔVraR psas016p-luc+ was induced with 5x MIC
of fosfomycin, D-cycloserine, tunicamycin, bacitracin,
flavomycin, vancomycin, teicoplanin, oxacillin and
daptomycin and 1x MIC of lysostaphin, for 60 min. The
luciferase activities ranged from 1.5-fold higher to 10-
fold lower than those in uninduced cultures, showing
that none of the antibiotics used could induce sas016
expression in absence of VraR.
Conclusions
In this study, we describe the application of a highly
sensitive luciferase-reporter gene construct for indirectly
measuring CWSS induction kinetics in S. aureus.T h i s
system was used to compare induction characteristics of
ten different cell wall active antibiotics with diverse
enzymatic targets or modes of action. Induction of the
CWSS by all ten antibiotics could be precisely quantified
and while all ten antibiotics induced the CWSS, induc-
tion patterns varied greatly and were highly antibiotic-
specific. Each antibiotic produced unique induction
curves, which differed in lag times before induction,
maximal rates of induction and peak induction levels.
Induction kinetics were also strongly antibiotic con-
centration-dependent, to different extents for each anti-
biotic, and generally correlated inversely with decreasing
OD values, therefore linking induction kinetics to anti-
biotic activity. However, there were no obvious trends
linking antibiotics acting on similar stages of CWSS
with specific induction patterns. Therefore, the signal
triggered by all of the antibiotics, that is responsible for
activating VraS signal transduction, does not appear to
be linked to any particular enzymatic target, as CWSS
induction was triggered equally strongly by antibiotics
targeting early cytoplasmic stages (e.g. fosfomycin) and
late extracellular polymerization stages (e.g. oxacillin) of
peptidoglycan synthesis. This is a key difference between
the VraSR system of S. aureus and the homologous
LiaRS systems of other Gram-positive bacteria such as
B. subtilis and S. mutans, which are only activated by
lipid-II interacting antibiotics, such as bacitracin, ramo-
planin and nisin [15-18]. The increased induction spec-
trum could account for the larger size of the S. aureus
CWSS and its protective role against more different
classes of antibiotics. Although no direct links between
induction properties and the impact of the CWSS on
respective resistance phenotypes could be found.
Previous studies have reported large differences in
CWSS induction characteristics. However, most studies
were performed on different strains and using different
experimental conditions. Variations in characteristics
observed for the ten antibiotics tested here, indicated
that each antibiotic has optimal induction conditions
that should be determined before CWSS studies are car-
ried out, including the right antibiotic concentration for
the strain used and the optimal sampling time point to
measure maximal induction.
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